Open access
Open access
Powered by Google Translator Translator

Pediatrics – Cardiology

AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents.

23 Jun, 2022 | 13:03h | UTC

Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement From the American Heart Association – Circulation Research

News Release: Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk – American Heart Association

 


Cohort Study: Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA.

22 Jun, 2022 | 12:07h | UTC

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases – The Lancet

Commentaries:

COVID-19 mRNA vaccination and myocarditis or pericarditis – The Lancet

Myocarditis and Pericarditis After the COVID-19 mRNA Vaccination – American College of Cardiology

Related:

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents – JAMA Cardiology

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

 


Guidelines for the use of cardiac magnetic resonance in pediatric congenital and acquired heart disease.

22 Jun, 2022 | 11:31h | UTC

Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association – Circulation: Cardiovascular Imaging

 


Analysis of age, sex, lack of response to intravenous immunoglobulin, and development of coronary artery abnormalities in a large cohort of children with Kawasaki disease in Japan.

14 Jun, 2022 | 10:54h | UTC

Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan – JAMA Network Open

 


Isolated coarctation of the aorta: current concepts and perspectives.

14 Jun, 2022 | 10:49h | UTC

Isolated Coarctation of the Aorta: Current Concepts and Perspectives – Frontiers in Cardiovascular Medicine

 


M-A: Use of benznidazole to treat chronic Chagas disease.

3 Jun, 2022 | 11:19h | UTC

Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis – PLOS Neglected Tropical Diseases

 


Systematic Review: Corticosteroids for the treatment of Kawasaki disease in children.

1 Jun, 2022 | 11:05h | UTC

Corticosteroids for the treatment of Kawasaki disease in children – Cochrane Library

Summary: Using corticosteroids to treat Kawasaki disease – Cochrane Library

 


Consensus Paper: Recommendations for cardiovascular magnetic resonance and computed tomography in congenital heart disease.

31 May, 2022 | 11:24h | UTC

Recommendations for cardiovascular magnetic resonance and computed tomography in congenital heart disease: a consensus paper from the CMR/CCT working group of the Italian Society of Pediatric Cardiology (SICP) and the Italian College of Cardiac Radiology endorsed by the Italian Society of Medical and Interventional Radiology (SIRM) Part I – La radiologia medica

 


New study looks at heart defect risk in children of people with heart defects.

26 May, 2022 | 10:38h | UTC

News Release: New study looks at heart defect risk in children of people with heart defects – American Heart Association

Original Study: Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers – Circulation: Genomic and Precision Medicine

 


AHA Scientific Statement: Ambulatory blood pressure monitoring in children and adolescents.

24 May, 2022 | 10:47h | UTC

Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association – Hypertension

News Release: Statement updates ambulatory blood pressure classification in children and adolescents – American Heart Association

 


Cohort Study: Clinical features and natural history of preadolescent nonsyndromic hypertrophic cardiomyopathy.

23 May, 2022 | 00:45h | UTC

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy – Journal of the American College of Cardiology

Commentary: Clinical Features and Course of Preadolescent Hypertrophic Cardiomyopathy – American College of Cardiology

 


Position Paper: Diagnosis and management of rare cardiomyopathies in adult and pediatric patients.

3 May, 2022 | 10:24h | UTC

Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) – International Journal of Cardiology

 


AHA Scientific Statement: SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults.

12 Apr, 2022 | 09:59h | UTC

SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association – Circulation

News Release: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association

Commentary: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD

 


Acute phase of Kawasaki disease: a review of national guideline recommendations.

12 Apr, 2022 | 08:32h | UTC

Acute phase of Kawasaki disease: a review of national guideline recommendations – European Journal of Pediatrics

 


AHA Scientific Statement: addressing social determinants of health and mitigating health disparities across the lifespan in congenital heart disease.

11 Apr, 2022 | 01:31h | UTC

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association – Circulation

Commentary: Social determinants of health affect care for people with congenital heart disease – American Heart Association

 


Review: Epigenetics in congenital heart disease.

8 Apr, 2022 | 10:12h | UTC

Epigenetics in Congenital Heart Disease – Journal of the American Heart Association

 


Cohort Study: Childhood cardiovascular risk factors and adult cardiovascular events.

5 Apr, 2022 | 08:23h | UTC

Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.

1 Apr, 2022 | 08:45h | UTC

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials – eBioMedicine

Commentary: Network meta-analysis rates treatments for Kawasaki disease – medwire News

 


Review: Sudden cardiac death in congenital heart disease.

30 Mar, 2022 | 10:17h | UTC

Sudden cardiac death in congenital heart disease – European Heart Journal

 

Commentary on Twitter

 


Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals.

29 Mar, 2022 | 10:09h | UTC

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Related:

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

 


AHA Scientific Statement: Advances in managing transition to adulthood for adolescents with congenital heart disease.

18 Mar, 2022 | 08:19h | UTC

Advances in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: A Practical Approach to Transition Program Design: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

News Release: For youth with a heart defect, shift to adult-focused care is key to health, quality of life – American Heart Association

 


RCT: In pediatric ICUs, a bundled intervention that emphasized a physiologically focused cardiopulmonary resuscitation training did not improve outcomes in cardiac arrest.

11 Mar, 2022 | 09:37h | UTC

Effect of Physiologic Point-of-Care Cardiopulmonary Resuscitation Training on Survival With Favorable Neurologic Outcome in Cardiac Arrest in Pediatric ICUs: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

Commentary: CPR Intervention Failed to Improve Survival in Kids With Cardiac Arrest — Physiologically focused CPR training did not lead to difference in survival to discharge – MedPage Today (free registration required)

 

Commentary on Twitter

 


ACR/Vasculitis Foundation Guideline for the management of Kawasaki Disease.

9 Mar, 2022 | 10:01h | UTC

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

 


AAP Clinical Report: Recognition and management of cardiovascular insufficiency in the very low birth weight newborn.

4 Mar, 2022 | 08:54h | UTC

Recognition and Management of Cardiovascular Insufficiency in the Very Low Birth Weight Newborn – Pediatrics

 


Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

3 Mar, 2022 | 08:43h | UTC

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong – JAMA Pediatrics

Commentary: Study: Dosing change could reduce COVID-19 vaccine heart side effect in teens – UPI

Related:

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

 


Stay Updated in Your Specialty

No spam, just news.